The Novo Nordisk Foundation chooses Eviden to build “Gefion” in
Denmark, one of the world’s most powerful AI supercomputers
Press Release
The Novo Nordisk Foundation chooses
Eviden to build “Gefion” in Denmark, one of the world’s most
powerful AI supercomputers
Paris, France – March 19, 2024
– Eviden, the Atos Group business leading in advanced
computing, today announces a new contract with the Danish Centre
for AI Innovation, owned by the Novo Nordisk Foundation and the
Export and Investment Fund of Denmark, to construct a
state-of-the-art AI supercomputer in Denmark. The supercomputer is
designed to cater to large-scale projects that utilize artificial
intelligence and prioritize the highest level of security to
support Danish data sovereignty. The new supercomputer is expected
to be one of the most powerful AI supercomputers in the world. Its
goal is to accelerate research and innovation in various fields
such as healthcare, life sciences, and the green transition.
It will deliver 6 Exaflops of FP8 AI performance
and is based on the NVIDIA DGX SuperPODTM architecture. Eviden will
deliver, install, and configure the supercomputer, as well as
provide the maintenance and technical support during its entire
lifetime.
The supercomputer, named Gefion, is expected to
be ready for pilot projects before the end of the year. It will be
housed in Denmark’s newly established national centre for AI
innovation and will provide researchers from Denmark’s public and
private sectors access to an advanced supercomputer optimized for
AI.
“We’re proud to be working with Novo Nordisk
Foundation and the Danish Centre for AI Innovation to deliver the
AI supercomputer in Denmark to provide an unprecedented potential
to accelerate groundbreaking scientific discoveries in areas such
as drug discovery, disease diagnosis and treatment,” said
Dr. Cédric Bourrasset, Head of HPC-AI and Quantum
Computing, Eviden, Atos Group. “This new supercomputer
will be a powerful resource to further boost AI research and
collaboration between academia and Danish industry in Denmark’s
already thriving AI-based research ecosystem.”
Mads Krogsgaard Thomsen, CEO of the Novo
Nordisk Foundation, said, “Eviden is renowned for being
the leading expert in AI supercomputing. They are therefore the
ideal choice to support this exciting project and help Denmark’s
brilliant researchers and innovators rise to the next level.”
“AI is helping researchers find solutions to
many of humanity’s biggest challenges in healthcare,
sustainability, energy and more” said Charlie Boyle, Vice
President, DGX platforms at NVIDIA. “Built by Eviden with
NVIDIA DGX H100 AI supercomputing, the Novo Nordisk Foundation
Gefion system can advance research and development in Denmark with
transformative, full-stack AI infrastructure.”
Established in Denmark in 1924, the Novo Nordisk
Foundation is an enterprise foundation with philanthropic
objectives. Its vision is to improve people’s health and the
sustainability of society and the planet, and its mission is to
progress research and innovation in the prevention and treatment of
cardiometabolic and infectious diseases as well as to advance
knowledge and solutions to support a green transformation of
society.
***
Editorial Notes
About the supercomputer
The new supercomputer is a large-scale NVIDIA
DGX SuperPOD comprised of 191 NVIDIA DGX H100 systems (individual
computer systems) with a total of 1,528 NVIDIA H100 Tensor Core
GPUs and 382 Intel Xeon Platinum CPUs connected via the NVIDIA
Quantum-2 InfiniBand networking platform. It will include storage
from DDN. The system will also use state-of-the-art NVIDIA software
platforms such as NVIDIA CUDA Quantum, an open-source hybrid
quantum computing platform that features powerful simulation tools
and capabilities to program hybrid CPU, GPU, and quantum processing
unit (QPU) systems. The H100 GPU’s Hopper chip architecture is
designed to solve the world’s most challenging AI problems and is
four times faster at training tasks on large language models like
GPT-3 compared to its predecessor.
About
Eviden1
Eviden is a next-gen technology leader in
data-driven, trusted and sustainable digital transformation with a
strong portfolio of patented technologies. With worldwide leading
positions in advanced computing, security, AI, cloud and digital
platforms, it provides deep expertise for all industries in more
than 47 countries. Bringing together 47,000 world-class talents,
Eviden expands the possibilities of data and technology across the
digital continuum, now and for generations to come. Eviden is an
Atos Group company with an annual revenue of c. € 5 billion.
About Atos
Atos is a global leader in digital
transformation with c. 95,000 employees and annual revenue of c. €
11 billion. European number one in cybersecurity, cloud and
high-performance computing, the Group provides tailored end-to-end
solutions for all industries in 69 countries. A pioneer in
decarbonization services and products, Atos is committed to a
secure and decarbonized digital for its clients. Atos is a SE
(Societas Europaea), and listed on Euronext Paris.
The purpose of Atos is to help design the future
of the information space. Its expertise and services support the
development of knowledge, education and research in a multicultural
approach and contribute to the development of scientific and
technological excellence. Across the world, the Group enables its
customers and employees, and members of societies at large to live,
work and develop sustainably, in a safe and secure information
space.
Press contact
Laura Fau | laura.fau@atos.net | +33
(0) 6 73 64 04 18
1 Eviden business is operated through the
following brands: AppCentrica, ATHEA, Cloudamize, Cloudreach,
Cryptovision, DataSentics, Edifixio, Energy4U, Engage ESM, Evidian,
Forensik, IDEAL GRP, In Fidem, Ipsotek, Maven Wave, Profit4SF, SEC
Consult, Visual BI, Worldgrid, X-Perion. Eviden is a registered
trademark. Eviden is a registered trademark. © Eviden SAS,
2024.
- PR - The Novo Nordisk Foundation chooses Eviden to build
“Gefion” in Denmark, one of the world’s most powerful AI
supercomputers
Atos (EU:ATO)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Atos (EU:ATO)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
